Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals,…
- Recall date
- February 9, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0340-2026
- FDA classification
- Class II
- Brand / firm
- Meitheal Pharmaceuticals, Inc
- Sold / distributed
- U.S. Nationwide
Why it was recalled
Defective Delivery System: Missing or duplicated needles within the injection kit
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Get recall alerts
Free email alert whenever Meitheal Pharmaceuticals, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Meitheal Pharmaceuticals, Inc